1.Quantitative expression and localization of cysteine and aspartic proteases in human abdominal aortic aneurysms.
Fabian LOHOEFER ; Christian REEPS ; Christina LIPP ; Martina RUDELIUS ; Felix HAERTL ; Edouard MATEVOSSIAN ; Alma ZERNECKE ; Hans Henning ECKSTEIN ; Jaroslav PELISEK
Experimental & Molecular Medicine 2014;46(5):e95-
Cysteine and aspartic proteases possess high elastolytic activity and might contribute to the degradation of the abdominal aortic aneurysm (AAA) wall. The aim of this study was to analyze, in detail, the proteases (cathepsins B, D, K, L and S, and inhibitor cystatin C) found in human AAA and healthy aortic tissue samples. The vessel walls from AAA patients (n=36) and nonaneurysmal aortae (n=10) were retrieved using conventional surgical repair and autopsy methods. Serum samples from the same AAA patients and 10 healthy volunteers were also collected. Quantitative expression analyses were performed at the mRNA level using real-time reverse transcriptase-PCR (RT-PCR). Furthermore, analyses at the protein level included western blot and immunoprecipitation analyses. Cellular sources of cysteine/aspartic proteases and cystatin C were identified by immunohistochemistry (IHC). All cysteine/aspartic proteases and cystatin C were detected in the AAA and control samples. Using quantitative RT-PCR, a significant increase in expression was observed for cathepsins B (P=0.021) and L (P=0.018), compared with the controls. Cathepsin B and cystatin C were also detected in the serum of AAA patients. Using IHC, smooth muscle cells (SMCs) and macrophages were positive for all of the tested cathepsins, as well as cystatin C; in addition, the lymphocytes were mainly positive for cathepsin B, followed by cathepsins D and S. All cysteine/aspartic proteases analyzed in our study were detected in the AAA and healthy aorta. The highest expression was found in macrophages and SMCs. Consequently, cysteine/aspartic proteases might play a substantial role in AAA.
Aged
;
Aorta/enzymology
;
Aortic Aneurysm, Abdominal/*enzymology
;
Aspartic Acid Proteases/genetics/*metabolism
;
Case-Control Studies
;
Cathepsins/genetics/metabolism
;
Cysteine Proteases/genetics/*metabolism
;
Humans
;
Lymphocytes/enzymology
;
Macrophages/enzymology
;
Middle Aged
;
Myocytes, Smooth Muscle/enzymology
;
RNA, Messenger/genetics/metabolism
2.Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability.
Sung Hoon YU ; Jae Myung YU ; Hyung Joon YOO ; Seong Jin LEE ; Dong Hyun KANG ; Young Jung CHO ; Doo Man KIM
Yonsei Medical Journal 2016;57(2):373-381
PURPOSE: Proliferation of vascular smooth muscle cells (VSMCs) plays a crucial role in atherosclerosis. Rutin is a major representative of the flavonol subclass of flavonoids and has various pharmacological activities. Currently, data are lacking regarding its effects on VSMC proliferation induced by intermittent hyperglycemia. Here, we demonstrate the effects of rutin on VSMC proliferation and migration according to fluctuating glucose levels. MATERIALS AND METHODS: Primary cultures of male Otsuka Long-Evans Tokushima Fatty (OLETF) rat VSMCs were obtained from enzymatically dissociated rat thoracic aortas. VSMCs were incubated for 72 h with alternating normal (5.5 mmol/L) and high (25.0 mmol/L) glucose media every 12 h. Proliferation and migration of VSMCs, the proliferative molecular pathway [including p44/42 mitogen-activated protein kinases (MAPK), mitogen-activated protein kinase kinase 1/2 (MEK1/2), p38 MAPK, phosphoinositide 3-kinase (PI3K), c-Jun N-terminal protein kinase (JNK), nuclear factor kappa B (NF-kappaB), and Akt], the migratory pathway (big MAPK 1, BMK1), reactive oxygen species (ROS), and apoptotic pathway were analyzed. RESULTS: We found enhanced proliferation and migration of VSMCs when cells were incubated in intermittent high glucose conditions, compared to normal glucose. These effects were lowered upon rutin treatment. Intermittent treatment with high glucose for 72 h increased the expression of phospho-p44/42 MAPK (extracellular signal regulated kinase 1/2, ERK1/2), phospho-MEK1/2, phospho-PI3K, phospho-NF-kappaB, phospho-BMK1, and ROS, compared to treatment with normal glucose. These effects were suppressed by rutin. Phospho-p38 MAPK, phospho-Akt, JNK, and apoptotic pathways [B-cell lymphoma (Bcl)-xL, Bcl-2, phospho-Bad, and caspase-3] were not affected by fluctuations in glucose levels. CONCLUSION: Fluctuating glucose levels increased proliferation and migration of OLETF rat VSMCs via MAPK (ERK1/2), BMK1, PI3K, and NF-kappaB pathways. These effects were inhibited by the antioxidant rutin.
Animals
;
Caspase 3/metabolism
;
Cell Movement/*drug effects
;
Cell Proliferation/*drug effects
;
Flavonoids/*pharmacology
;
Glucose/*metabolism/pharmacology
;
JNK Mitogen-Activated Protein Kinases
;
MAP Kinase Kinase 1
;
Male
;
Mitogen-Activated Protein Kinase 3
;
Muscle, Smooth, Vascular/cytology/*drug effects/enzymology
;
Myocytes, Smooth Muscle/metabolism
;
NF-kappa B/metabolism
;
Phosphatidylinositol 3-Kinases
;
Protein Kinase Inhibitors/*pharmacology
;
Rats
;
Rats, Inbred OLETF
;
Rats, Long-Evans
;
Reactive Oxygen Species/metabolism
;
Rutin/*pharmacology
;
p38 Mitogen-Activated Protein Kinases/metabolism